Transcript Highlights:

• Now we'll move into just a few slides on how HHS provides and pays for substance use disorder services
• If a Medicaid patient needs residential treatment for a substance use disorder or inpatient care for
• Effective care for serious mental illness and substance use disorders follows what clinicians call a
• or an individuals with a substance use disorder or an ongoing mental illness, they tend to be from a
• However, in the final section, it just noted substance use disorders, and we discussed adding serious

Committee: Joint Tribal and State Relations Committee

Transcript Highlights:

• Most recently, two gentlemen were in my care with a history of stimulant use disorder.
• And substance use disorder is no different.
• I am also someone with a diagnosis of schizoaffective disorder.
• I am also someone with a diagnosis of schizoaffective disorder.
• I live with multiple rare and painful disorders.

Committee: Joint Joint Committee on the Judiciary

Summary: The Joint Committee on the Judiciary held a lengthy hearing on several juvenile justice and parole-related bills, with much of the testimony focused on H. 2051/S. 1087 to end lifetime parole for juveniles and emerging adults, and H. 1923 to raise the age of juvenile court jurisdiction to include 18-, 19-, and 20-year-olds. Chairs Brandy Fluker-Reid and Lydia Edwards opened the hearing by noting the large number of bills and witnesses, the need to keep testimony moving, and special procedures for incarcerated witnesses and sensitive testimony. They also acknowledged the historic nature of the hearing being chaired by two Black women attorneys. No votes were taken during the hearing itself. Many incarcerated speakers and advocates supported ending lifetime parole, arguing that young people can change, that lifetime supervision creates constant fear of technical violations, and that it undermines rehabilitation, family stability, employment, and reintegration. Several testified about their own trauma, youth, and growth in prison programs, while others emphasized the costs of decades of supervision and the racial disparities in the system. Support also came from elected officials, UTEC, the Transformational Prison Project, United Way, CPCS’s Youth Advocacy Division, the Massachusetts Coalition to Prevent Gun Violence, and others, who said juvenile systems are better suited to developmentally appropriate treatment and that the bills would improve public safety and reduce recidivism. There was also opposition, including testimony from family members of a murder victim who argued that lifetime parole should remain for serious violent crimes and that some offenders are not sufficiently rehabilitated. One virtual witness described a family tragedy involving the kidnapping and murder of her infant nephew and warned that ending lifetime parole could remove needed long-term supervision for dangerous offenders. In addition to the juvenile justice bills, the committee heard testimony on H. 1867, a bill related to continuing care for severe mental illness, and H. 2063, which would increase penalties for assaults on correction officers and other prison staff; the correction officers’ union supported H. 2063 and related safety bills. The hearing continued with many more witnesses and bill topics, but no final committee action was announced in the portion provided.

Transcript Highlights:

• I had the disorders in Pittsburgh.
• I also know that we're only treating about 30% of people with opioid use disorder.
• Seventy percent of people with opioid use disorder are still out there.
• </c><01:03:29.039><c> play</c> medications for opiate use disorder play medications for opiate use disorder
• They don't disorder. It confuses them.

Summary: The subcommittee met on October 14, approved the minutes, and then took up a large group of staff-suggested amendments to multiple regulations. Those staff amendments were approved without objection and were described as technical changes needed to comply with KRS Chapter 13A and other governing law. The committee then moved out of order to consider Kentucky Board of Medical Licensure regulation 2011 KAR 9:270, which governs buprenorphine prescribing and related standards. Board representatives said the regulation has been updated over time since 2015 and that the current amendments are intended to streamline the rule, remove outdated federal references such as the X-waiver, narrow education requirements to addiction-related topics, and create exceptions for settings like emergency rooms and certain pain treatment situations. The agency amendment would also allow buprenorphine monoproduct for up to 30 days when a patient is transitioning from a full opioid agonist, and would add physicians certified in addiction medicine as eligible specialty consultants. Board officials said the regulation was developed through a two-year process with a work group, informal outreach to medical organizations, and multiple comment periods, and they argued the rule is working because overdose deaths have declined and provider numbers have increased. Several witnesses and committee members raised concerns that the regulation remains too restrictive. Senator Rocky Adams noted that major medical organizations had said the proposed language could restrict access and worsen overdose risk, and he questioned whether the committee was being asked to choose between conflicting expert views. Opponents, including a medical student, a recovery advocate, and Dr. Colleen Ryan of the Kentucky Society of Addiction Medicine, argued the rule is outdated, creates unnecessary barriers to buprenorphine treatment, and should be repealed or substantially revised to align with federal guidance and evidence-based care. They said rigid requirements can discourage treatment and that addiction should be treated like other chronic illnesses. No final vote on the medical licensure regulation is reflected in the transcript excerpt, and the discussion ended with the chair preparing to hear from additional opponents.

Transcript Highlights:

• Buprenorphine is a gold standard treatment for opioid use disorder.
• Opioid use disorder is a incarcerated.
• </c> stigma around uh uh opioid use disorder stigma around uh uh opioid use disorder and<01:31:15.760
• abuse disorder, there should be<01:47:50.080><c> a</c><01:47:50.320><c> stigma.
• Um, and so I guess the first disorder.

Summary: The committee approved the September 18 minutes and then heard testimony on House Bill 534, which would automatically seal dismissed eviction filings and protect youth from public disclosure in forcible detainer cases. Rep. Susan Tyler Whitten and George Ecklan of the Coalition for the Homeless said the bill is aimed at reducing housing barriers for Kentuckians, especially those with dismissed cases, while preserving landlords’ rights to pursue rent, collections, damages, and other legal remedies. They said the proposal was developed with input from landlords, clerks, judges, AOC, and service providers, and noted that similar laws exist in other states. Several members, including Sen. Neimes, Rep. Deetsz, Rep. Cole Carney, and Sen. Thomas, expressed support while emphasizing that the bill is narrowly tailored to dismissed cases and should not affect legitimate landlord claims; Sen. Wheeler raised concerns about cases involving settlements or delays and whether future landlords should know about them. The sponsors responded that the bill only covers dismissed actions, that dismissals require a judge’s order, and that the goal is to remove barriers created by records that remain publicly visible even when a case is resolved. The committee then took up Senate Bill 111 on juvenile justice. Commissioner Randy White, Kentucky Hospital Association President Nancy Galvanny, and Dr. Clark Lester of the University of Kentucky said the bill would require a secure state-run facility for youth with high-acuity mental health needs in detention and, until that is built, create a process with incentives for private hospitals to provide inpatient treatment with safeguards and increased compensation. They argued that detention is not an appropriate setting for severely mentally ill, violent youth and that private psychiatric hospitals often refuse these referrals or discharge them early. Dr. Lester cited recent referral data showing high denial rates for juvenile justice youth in private hospitals in August and September, often due to aggression, and described a case in which repeated placement attempts failed because of violent and self-harming behavior. The presenters said the bill is intended to fill a service gap and improve safety and outcomes for youth, staff, and hospitals, but no vote or final action on the bill was taken in the portion of the meeting provided.

Transcript Highlights:

• more significant concern is that of our out-of-control psychiatric profession treating this as a genetic
• </c><04:10:11.199><c> problem</c><04:10:12.319><c> in</c> treating this as a genetic problem in treating
• this as a genetic problem in which<04:10:12.960><c> people</c><04:10:13.279><c> should</c><04:10:13.600
• It was not a genetic disease that required surgeries or permanently changing people's lives.
• It was not a genetic It was not a genetic uh<04:11:06.239><c> disease</c><04:11:07.680><c> that</c><04

Transcript Highlights:

• When you live with substance use disorder, a disease that's scientifically defined as a disease that
• understanding through interactions between law enforcement and individuals with autism spectrum disorder
• addition to kind of signifying to law enforcement that this may be a person with autism spectrum disorder
• I'm talking about auditory processing disorders, people with hearing issues, people with speaking issues
• in their life, maybe someone has dementia in their life, maybe someone has an auditory processing disorder

Bills: S0132 , S0418 , S0646 , S0820 , S1734

Committee: Senate Appropriations Committee on Criminal and Civil Justice

Transcript Highlights:

• So with youth and adolescent, we're also opening up a substance use disorder unit.
• This is our first residential substance use disorder treatment.
• Do they have access to services and people that are trained to provide substance use disorder services
• So there is a disallowance that says Medicaid cannot pay for a substance use disorder service if those
• Our residential units for substance use disorder, we cannot pay for those with Medicaid dollars, but

Summary: The House Health Services Subcommittee met to approve the October 7, 2024 minutes and then shifted to behavioral health as the main topic. Representatives Woodridge and Vaught described the work of the behavioral health working group, saying Arkansas needs a more proactive system that improves access, reduces red tape, and focuses on a few achievable policy changes for the 2027 session rather than many bills. Members discussed barriers such as low reimbursement, workforce shortages, licensing and credentialing hurdles, rural access problems, and the need to better use community providers, compacts, and step-down services. Director Paula Stone of DHS’s Office of Substance Abuse and Mental Health gave a detailed overview of the behavioral health system. She said Medicaid pays for more than 75% of behavioral health services in Arkansas and explained that when people are jailed or admitted to the state hospital, Medicaid generally stops, leaving state general revenue to cover care. She described current efforts including family-centered treatment for children, community reintegration group homes, a new adolescent substance use disorder residential unit, expanded community mental health center contracts, a secured restoration unit to reduce state hospital backlogs, and an IMD waiver to allow Medicaid payment for certain residential services. She also said DHS is working on crisis services, forensic evaluations, and provider rebidding in areas previously served by ERISA. Members asked about reimbursement for jail services, the lack of a statewide behavioral health dashboard, civil commitment options, crisis stabilization units, and whether Arkansas should expand step-down or long-term facilities for people who cannot safely return to the community. Stone said the state hospital backlog remains significant, average stays are still about 14 months, and crisis stabilization units have had mixed success, with Fort Smith and Jonesboro performing better than Fayetteville and Little Rock. The meeting ended with a commitment to continue the work, with more substantive discussion planned for August.

Transcript Highlights:

• here in Massachusetts for treatment of adults with PTSD, anxiety, depression, and substance use disorders
• here in Massachusetts for treatment of adults with PTSD, anxiety, depression, and substance use disorders
• to profoundly alter the trajectory of patients struggling with these debilitating mental health disorders
• is a pilot program, that it does encompass all types of therapeutic efforts around substance use disorder
• Complete resolution of symptoms of opioid use disorder in 88% of patients in a single dose.

Committee: Joint Joint Committee on Mental Health, Substance Use and Recovery

Summary: The hearing opened with remarks from House Chair Mindy Domb and Senate Vice Chair Robyn Kennedy, who outlined procedures for the hybrid public hearing, noted the committee would hear testimony on 15 bills related to treatment settings, and recognized members present. The first major bill discussed was H. 4200, authorizing a pilot program for psychedelic-assisted treatment in licensed facilities. Representative Jim O’Day and witnesses from Control Z supported the bill, describing it as a tightly controlled, medically supervised pilot with DPH oversight, limited sites, and screening requirements. Committee members asked about the number of sites and whether Column Health still existed; witnesses said the bill contemplated three separate pilot programs and that Column Health no longer existed after being purchased by another company. The committee also heard testimony on S. 1405 to make the drug stewardship program permanent by removing its 2026 sunset date. Senator John Keenan and others said the program helps collect and safely dispose of unused medications, reduces diversion, and should remain in place because manufacturers should bear disposal costs. A member from Boston added support based on local concerns about people searching through bags for drugs, and Keenan explained the original sunset reflected pilot status and industry pushback. A large portion of the hearing focused on S. 1394 and H. 2193, which would strengthen implementation of the 2023 Roadmap for Behavioral Health Reform. The Children’s Mental Health Campaign, Parent/Professional Advocacy League, Massachusetts Association for Mental Health, and Elliott Community Human Services testified that the roadmap’s helpline, community behavioral health centers, and crisis services are important but unevenly implemented. They urged a single point of accountability within EOHHS, regular strategic planning, a public data dashboard, and financial analysis of the behavioral health system and the access and crisis intervention trust fund. Witnesses said commercial insurance often does not fully reimburse community behavioral health center services, making sustainability difficult, and asked for better coordination across agencies and crisis response systems. Committee members asked whether the roadmap includes substance use disorder; witnesses said it is intended to cover behavioral health broadly, including mental health and substance use. The committee also heard testimony on bills to ban aversives and on suicide prevention signage. Lisa Jean Graff testified in support of S. 1394 by urging a statewide ban on aversive practices, including electric shock, withholding food or bathroom access, and other painful interventions, arguing disabled people deserve the same protections from harm as others. Fonda Bryant and Carol McLean supported a bill requiring suicide prevention signs on tall parking garages, describing personal experiences and saying the signs could create a brief pause and connect people to 988 or other help. McLean said her son died by suicide from a parking garage and that signage might have made a difference. The committee also heard strong testimony in support of creating intensive stabilization and treatment units within DMH facilities (S. 1398/H. 2204), with the Massachusetts Nurses Association and a DMH nurse arguing that highly assaultive patients need specialized, more secure units to protect staff and other patients and to improve care. Additional testimony supported creating a dedicated board for licensed mental health counselors (H. 4696/S. 1382), with Rep. John Badger, the Mass Mental Health Counselors Association, and others saying LMHCs are a large and growing workforce that needs its own licensing board, clearer standards, and faster implementation of existing licensure reforms. The committee also heard extensive testimony on H. 2223 regarding benzodiazepines and non-benzodiazepine hypnotics. Survivors and advocates described severe withdrawal, lack of informed consent, cognitive harms, and long-term disability, while a physician supported the bill as a way to improve disclosure of risks. Finally, the committee heard multiple witnesses in favor of H. 2231/S. 1383 to establish peer-run respite centers statewide. Advocates and people with lived experience said peer respites provide non-coercive, home-like alternatives to hospitalization, can reduce trauma and repeated admissions, and may be especially important for marginalized communities; they also cited cost savings and existing positive outcomes from current respite programs. No votes or final committee actions were taken during the hearing portion reflected in the transcript.

Transcript Highlights:

• Disorders Awareness Month.
• Members, House Resolution 306 recognizes March 2025 as Bleeding Disorders Awareness Month.
• Bleeding disorders, including hemophilia, von Willebrand disease. and other clotting factor deficiencies
• These disorders impair the body's ability to form proper blood clots due to defects in clotting tractors
• Bleeding Disorders Awareness Month reminds us of the urgent need for research, improved treatment and

Transcript Highlights:

• and Machine Learning Approach for Identifying Potential Salivary Biomarkers of Major Depressive Disorder
• and machine learning approach for identifying potential salivary biomarkers of major depressive disorder
• But major depressive disorder is a real clinical disease, or psychiatric disease, and it's the leading
• But on a more human level, major depressive disorder, or depression, is shown by when students who are
• It cannot diagnose you with any sort of disease or any sort of disorder.

Committee: House House Science & Technology Committee of Reference

Summary: The Committee on Science and Technology met to hear a presentation from Ananya Lakaraju, a Hamilton High School junior, on her research into the biology of major depressive disorder. She described a project using saliva metabolomics and machine learning to identify potential biomarkers of depression from a UCSD dataset of 261 patient samples, explaining that the goal was to move beyond subjective screening toward more objective, biology-based diagnosis. She also discussed using multiple statistical methods and an ensemble AI model, along with SHAP and permutation importance, to identify top metabolites and related pathways, and said her work suggested some novel biomarkers and possible links to depression-related pathways. Lakaraju further explained a drug-discovery component of the project, in which she used pathway analysis and molecular docking software to identify a potential target protein and test candidate compounds, saying flupinazine showed the best binding energy in her simulations. She noted that the model achieved about 90% accuracy and a 97% AUC, and said she also built an app to collect mood and activity information to complement the biological data. Members asked questions about the metabolites, whether the findings were novel, how the saliva data were obtained, and how the app and future at-home testing might work. She said the biomarkers were computationally identified, the saliva data came from an online UCSD dataset rather than direct collection, and the app was intended to support more holistic diagnosis rather than replace clinicians. Committee members praised the presentation as impressive and timely, especially in light of the growing role of AI in medicine and the need for AI regulation. Lakaraju also spoke about her interest in coding and biology, her experience in robotics, and receiving the Governor’s Future Innovator of the Year Award. No formal votes or legislative actions were taken, and the meeting adjourned after the presentation and discussion.

Transcript Highlights:

• a crisis, such as the Baker Act for mental health crisis and the Marchman Act for substance use disorder
• The bill also implemented recommendations from the Commission on Mental Health and Substance Use Disorder
• you'll see, I have... to receive concerns or complaints on behalf of youth and behavioral health disorders
• The bill also implemented recommendations from the Commission on Mental Health and Substitute Disorder
• after struggling to maintain... ...for opioid use disorder after struggling to maintain sobriety in

Summary: The Human Services Subcommittee met to receive an update from the Florida Department of Children and Families on implementation of House Bill 7021, which revised the Baker Act and Marchman Act and was funded with a $50 million appropriation. Deputy Assistant Secretary Bill Hardin reported that the department has updated reference guides, training, administrative rules, and forms; launched regional behavioral health collaboratives; and created the Office of Children’s Behavioral Health Ombudsman. He said early data show continued declines in Baker Act use, high diversion rates from involuntary examinations through 988, mobile response teams, and care coordination, along with generally positive provider feedback on changes such as allowing psychiatric nurses to initiate emergency treatment orders and clarifying the 72-hour examination period. Hardin also described Marchman Act changes, including a streamlined petition process, remote testimony, improved discharge planning, and a new annual data report. He said the department has completed or is completing multiple training courses for providers and law enforcement, and has adopted or is finalizing numerous rules and forms. He reported that the regional collaboratives are identifying common statewide needs such as service capacity, resource sharing, funding flexibility, and peer support, while the ombudsman office is handling complaints and helping families navigate services. Members asked about whether the current funding is sufficient, future budget needs, outreach for the new ombudsman office, and services for juveniles. Hardin said DCF has posted legislative budget requests for additional forensic FACT services and short-term residential treatment beds, including children’s beds, and noted the ombudsman office is staffed with two FTEs and supported through existing complaint-management and regional systems. He said outreach is being done through regional collaboratives and coordination with other agencies, especially the Department of Education, and that juvenile transport and placement issues have improved with the new law. No votes were taken, and the meeting adjourned after the presentation and questions.

Transcript Highlights:

• Do you know if there's a definition that's used for what would constitute that disorder?
• Do you know if there's a definition that's used for what would constitute that disorder?
• So there aren't different levels of schizophrenia and schizoaffective disorder.
• These specific disorders with the current state of the law.
• And my clients with schizophrenia and schizoaffective disorder are different.

Bills: HB 1194 , HB 1221 , HB1738 , HB1913 , HB2177 , HB2178 , HB2180 , HB2229 , HB2282 , HB2448 , HB2492 , HB2777 , HB2984 , HB3357 , HB3553 , HB3602

Committee: House Criminal Jurisprudence

Keywords: emergency protection order, protective order, magistrate, criminal procedure, victim safety, family violence, domestic violence, stalking, assault, magistrate's order, temporary protection, court order duration, defendant restrictions, Article 17.292, Texas Code of Criminal Procedure, emergency restraining order, victim protection, firearm restriction, pretrial intervention, reimbursement fee

Summary: The committee first took up House Bill 2777 by Representative Rose, which would bar the death penalty for defendants who can prove by clear and convincing evidence that they had schizophrenia or schizoaffective disorder and active psychotic symptoms at the time of the offense. Rose said the bill would still hold defendants accountable through life without parole, would save money by avoiding lengthy capital litigation, and would address cases where severe mental illness was not adequately considered. Supporters from NAMI Texas, the Catholic bishops, and a forensic psychologist said the bill is narrowly tailored, consistent with neuroscience and moral principles, and would prevent executions of people whose psychosis substantially impaired reality testing. Committee members questioned how the bill interacts with existing competency and insanity law, whether the diagnosis is sufficiently defined, and whether the statute requires active psychosis at the time of the offense. An opponent argued the death penalty should remain available for juries to decide in all cases. The bill was left pending. The committee then heard House Bill 1221 by Representative Lozano, which would raise the cap on pretrial intervention program fees from $500 to $1,200. Lozano and a district attorney witness said the increase is needed because program costs have risen and the fees help make diversion programs self-sustaining, allowing first-time or low-level offenders to complete rehabilitation and potentially obtain expunction. Opponents from the Texas Fair Defense Project argued the higher fee could make diversion unaffordable for indigent defendants and undermine an important alternative to incarceration, especially where related supervision and monitoring costs already add up. Members discussed whether the fee applies only to PTI participants, how payment plans and waivers work, and whether ability to pay should be addressed more explicitly. The bill was left pending. Finally, the committee heard House Bill 1738 by Representative Jones, which would repeal Penal Code Section 21.06 and related Health and Safety Code references concerning homosexual conduct. Jones said the law is unconstitutional under Lawrence v. Texas, remains harmful on the books, and has led to confusion and unnecessary costs even though it is unenforceable. Supporters said the bill simply removes outdated language and protects civil liberties, while opponents from Texas Values argued the statute still serves as a statement that homosexual conduct is unacceptable and should remain as a warning, even if unenforceable. Members debated whether the law’s remaining language is merely symbolic or still harmful, and whether other criminal statutes already cover conduct such as prostitution, incest, and offenses involving minors. The bill was left pending after testimony.

Transcript Highlights:

• This bill prohibits prior authorization requirements for certain genetic medications prescribed by qualified

Committee: Senate Insurance

Summary: The Senate Insurance Committee met on May 13, 2026, adopted the May 6 minutes, and then took up several bills dealing with pharmacy benefit managers, prescription access, behavioral health coverage, and Citizens Property Insurance. HB 938, as amended, was the main PBM reform measure. After the committee adopted a large amendment set that narrowed the bill, members heard extensive testimony in support from Mark Bloom, Justin Joseph of Capital Rx, and Kathy Ue of Pontchartrain Cancer Center, all emphasizing transparency, pass-through pricing, reverse auctions, and patient access. Supporters described savings from reverse auctions and administrative models, while the cancer center testified that PBM-owned specialty pharmacy requirements can delay cancer medications and create financial hardship. The committee reported HB 938 favorably with amendments. The committee also heard HB 1154, which prohibits prior authorization for certain generic medications prescribed by qualified physicians, with a $250 cap discussed as a safeguard against higher-cost generics. The bill was supported by representatives from Ochsner Health and the Louisiana State Medical Society and was reported favorably. HB 909, which requires commercial coverage for behavioral health crisis services, was amended to clarify the insurers covered and then reported favorably with support from the Office of Behavioral Health and several outside groups. Testimony on HB 909 focused on reducing emergency room and law enforcement burdens and expanding crisis response capacity across the state. HB 1187, dealing with excess emergency assessment funds from Louisiana Citizens Property Insurance Corporation, was explained by the Insurance Commissioner as a way to transfer remaining Katrina-era assessment funds to the Fortified Roof Program. The committee reported the bill favorably. Finally, SB 511 and SB 512 were deferred and converted into a study resolution approach because there was not yet consensus on the underlying issue. The meeting then adjourned.

Transcript Highlights:

• Just to give you some highlights from this last year, February of 2025, a DNA match using genetic genealogy

Bills: HCR1026 , SB1130 , SB1134 , SB1131 , SB1132 , SB1133 , SB1142 , HR1049

Keywords: light pollution, bird mortality, migration, energy conservation, wildlife protection, University Hospitals Authority, funding, behavioral health, appropriation, adolescent health, emergency legislation, Oklahoma State University, Medical Authority, human performance, pharmaceutical expansion, emergency funding, juvenile justice, youth services, pandemic relief, healthcare

Transcript Highlights:

• And so I think that this bill, as written, discriminates against anyone who would identify or whose genetic

Summary: The House convened with prayer, the Pledge of Allegiance, approval of the prior journal, and recognition of guests, including Maricopa Community Colleges representatives, Club America students, and the Doctor of the Day, Dr. Jane Lyons. A proclamation was read honoring Maryvale High School’s Mariachi Las Panthers de Oro, with Representative Abeytia praising the students, director Mike Dominguez, and the program’s cultural and leadership impact. The chamber then moved through Committee of the Whole consideration of several Senate bills. SB 1011, SB 1170, SB 1400, SB 1456, SB 1476, SB 1511, and SB 1805 were advanced, with amendments adopted on SB 1400, SB 1456, SB 1511, and SB 1805. Debate centered on SB 1476, which would strengthen child neglect laws regarding exposure to dangerous controlled substances, and SB 1511, which dealt with CDL licensing and immigration status; opponents argued both were unnecessary or harmful, while supporters said they addressed public safety and trucking concerns. SB 1519 was retained on the calendar. The House then adopted the Committee of the Whole report and took up third reading votes, passing SB 1121, SB 1137, SB 1206, SB 1477, and SB 1786. In a second Committee of the Whole, the House advanced SB 1043, SB 1095, SB 1316, SB 1421, SB 1649, and SB 1711, with SB 1401 amended and moved forward. SB 1095 drew extended debate over gender-affirming care for minors, with supporters framing it as child protection and opponents warning it would override parents and doctors and harm transgender youth; SB 1316 concerned a rural health transformation fund; SB 1421 drew objections over banking, identification, and immigration-related burdens; and SB 1711 focused on school resources for recognizing inappropriate contact. The House adopted the Committee of the Whole reports, placed several bills on third reading, deferred some bills for engrossing, and then recessed and adjourned until the next day.

Transcript Highlights:

• And so I think that this bill, as written, discriminates against anyone who would identify or whose genetic

Transcript Highlights:

• And we've increased investment in forest assets through early site treatments and genetically improved

Committee: Senate Resources and Environment

Transcript Highlights:

• 4008, commerce and judiciary; HB 4009, data center, natural resources, energy and water; HB 4010, genetic

Transcript Highlights:

• I've been here for, I'm, the genetics have been here for six generations, and my son and daughter...

Committee: House Education

Transcript Highlights:

• You have genetic production. You have cow-calf production.

Committee: House Agricultural Affairs